Product Code: ETC4746714 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Netherlands Influenza Vaccine Market is projected to witness mixed growth rate patterns during 2025 to 2029. Beginning strongly at 0.01% in 2025, growth softens to 0.01% in 2029.
By 2027, the Influenza Vaccine market in Netherlands is anticipated to reach a growth rate of 0.01%, as part of an increasingly competitive Europe region, where Germany remains at the forefront, supported by United Kingdom, France, Italy and Russia, driving innovations and market adoption across sectors.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Influenza Vaccine Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Influenza Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Influenza Vaccine Market - Industry Life Cycle |
3.4 Netherlands Influenza Vaccine Market - Porter's Five Forces |
3.5 Netherlands Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2021 & 2031F |
3.6 Netherlands Influenza Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Netherlands Influenza Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Netherlands Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Netherlands Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Netherlands Influenza Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing influenza |
4.2.2 Government initiatives to promote influenza vaccination programs |
4.2.3 Growing elderly population in the Netherlands |
4.3 Market Restraints |
4.3.1 Limited access to vaccination services in rural areas |
4.3.2 Vaccine hesitancy among certain population segments |
4.3.3 High cost of influenza vaccines |
5 Netherlands Influenza Vaccine Market Trends |
6 Netherlands Influenza Vaccine Market Segmentations |
6.1 Netherlands Influenza Vaccine Market, By Vaccine type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Influenza Vaccine Market Revenues & Volume, By Quadrivalent, 2021-2031F |
6.1.3 Netherlands Influenza Vaccine Market Revenues & Volume, By Trivalent, 2021-2031F |
6.2 Netherlands Influenza Vaccine Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Influenza Vaccine Market Revenues & Volume, By Seasonal, 2021-2031F |
6.2.3 Netherlands Influenza Vaccine Market Revenues & Volume, By Pandemic, 2021-2031F |
6.3 Netherlands Influenza Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Influenza Vaccine Market Revenues & Volume, By Egg-based, 2021-2031F |
6.3.3 Netherlands Influenza Vaccine Market Revenues & Volume, By Cell-based, 2021-2031F |
6.4 Netherlands Influenza Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Influenza Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.4.3 Netherlands Influenza Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.5 Netherlands Influenza Vaccine Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Influenza Vaccine Market Revenues & Volume, By Injection, 2021-2031F |
6.5.3 Netherlands Influenza Vaccine Market Revenues & Volume, By Nasal Spray, 2021-2031F |
7 Netherlands Influenza Vaccine Market Import-Export Trade Statistics |
7.1 Netherlands Influenza Vaccine Market Export to Major Countries |
7.2 Netherlands Influenza Vaccine Market Imports from Major Countries |
8 Netherlands Influenza Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates |
8.2 Number of government-sponsored influenza vaccination campaigns |
8.3 Rate of adoption of new influenza vaccine technologies |
8.4 Average waiting time at vaccination centers |
9 Netherlands Influenza Vaccine Market - Opportunity Assessment |
9.1 Netherlands Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2021 & 2031F |
9.2 Netherlands Influenza Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Netherlands Influenza Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Netherlands Influenza Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 Netherlands Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Netherlands Influenza Vaccine Market - Competitive Landscape |
10.1 Netherlands Influenza Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |